↓ Skip to main content

American Association for Cancer Research

Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study

Overview of attention for article published in Cancer Epidemiology, Biomarkers & Prevention, March 2007
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
117 X users
facebook
2 Facebook pages
video
1 YouTube creator

Citations

dimensions_citation
143 Dimensions

Readers on

mendeley
93 Mendeley
Title
Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study
Published in
Cancer Epidemiology, Biomarkers & Prevention, March 2007
DOI 10.1158/1055-9965.epi-06-0865
Pubmed ID
Authors

Julia A. Knight, Maia Lesosky, Heidi Barnett, Janet M. Raboud, Reinhold Vieth

Abstract

Vitamin D, antiproliferative and proapoptotic in breast cancer cell lines, can reduce the development of mammary tumors in carcinogen-exposed rats. Current evidence in humans is limited with some suggestion that vitamin D-related factors may reduce the risk of breast cancer. We conducted a population-based case-control study to assess the evidence for a relationship between sources of vitamin D and breast cancer risk.

X Demographics

X Demographics

The data shown below were collected from the profiles of 117 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
France 1 1%
Unknown 91 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 16%
Student > Ph. D. Student 13 14%
Researcher 12 13%
Student > Master 11 12%
Student > Doctoral Student 7 8%
Other 23 25%
Unknown 12 13%
Readers by discipline Count As %
Medicine and Dentistry 31 33%
Agricultural and Biological Sciences 12 13%
Biochemistry, Genetics and Molecular Biology 11 12%
Nursing and Health Professions 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 12 13%
Unknown 17 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 76. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2024.
All research outputs
#566,531
of 25,591,967 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#213
of 4,856 outputs
Outputs of similar age
#870
of 90,752 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#2
of 51 outputs
Altmetric has tracked 25,591,967 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,856 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 90,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.